Gilead Sciences, Inc.
$GILD
Public valuation for Gilead Sciences, Inc. (GILD). Fair value, signal, and key metrics — no sign-in required.
Current Price
$149.05
42% Overvalued
Fair Value Estimate
$87
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $158.65
6% higher than current
Key Metrics
Market Cap
$184.8B
Forward P/E
15.6x
Operating Margin
-133.2%
Revenue Growth
6.4%
Get free watchlist alerts
Join the waitlist for valuation updates on $GILD and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.